Chemoinformaics analysis of 4-Hydroxy-2-methylacetophenone
Molecular Weight | 150.177 | nRot | 1 |
Heavy Atom Molecular Weight | 140.097 | nRig | 7 |
Exact Molecular Weight | 150.068 | nRing | 1 |
Solubility: LogS | -1.419 | nHRing | 0 |
Solubility: LogP | 1.771 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 23.3019 |
nHD | 1 | BPOL | 10.9001 |
QED | 0.621 |
Synth | 1.808 |
Natural Product Likeliness | 0.428 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.1 |
HIA | 0.004 |
CACO-2 | -4.488 |
MDCK | 0.0000213 |
BBB | 0.649 |
PPB | 0.742091 |
VDSS | 0.933 |
FU | 0.25898 |
CYP1A2-inh | 0.955 |
CYP1A2-sub | 0.917 |
CYP2c19-inh | 0.701 |
CYP2c19-sub | 0.143 |
CYP2c9-inh | 0.196 |
CYP2c9-sub | 0.911 |
CYP2d6-inh | 0.404 |
CYP2d6-sub | 0.854 |
CYP3a4-inh | 0.256 |
CYP3a4-sub | 0.265 |
CL | 11.676 |
T12 | 0.871 |
hERG | 0.025 |
Ames | 0.12 |
ROA | 0.108 |
SkinSen | 0.347 |
Carcinogencity | 0.556 |
EI | 0.994 |
Respiratory | 0.175 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.864329 |